-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 EmXN0bXeMvQTcq2ZPaDqi/RF2RjlYxKLy1zLpaIUTow+0EApH6KhpAye0jbDzb5o
 R0x16XoGGwJSRNKH48FnTw==

<SEC-DOCUMENT>0000950135-04-005851.txt : 20041222
<SEC-HEADER>0000950135-04-005851.hdr.sgml : 20041222
<ACCEPTANCE-DATETIME>20041222162704
ACCESSION NUMBER:		0000950135-04-005851
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20041216
ITEM INFORMATION:		Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20041222
DATE AS OF CHANGE:		20041222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ASPECT MEDICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000886235
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				954154357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24663
		FILM NUMBER:		041221172

	BUSINESS ADDRESS:	
		STREET 1:		141 NEEDHAM STREET
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02464-1505
		BUSINESS PHONE:		(617) 559-7857

	MAIL ADDRESS:	
		STREET 1:		141 NEWTON STREET
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02464-1505
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>b52897ame8vk.htm
<DESCRIPTION>8-K - ASPECT MEDICAL SYSTEMS, INC.
<TEXT>
<HTML>
<HEAD>
<TITLE>8-K - Aspect Medical Systems, Inc.</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="center" style="font-size: 12pt">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
WASHINGTON, D.C. 20549


<P>
<HR noshade width="26%" align="center" size="1">
<P>




<P align="center" style="font-size: 12pt">FORM 8-K


<P align="center" style="font-size: 12pt">CURRENT REPORT

<DIV align="center" style="font-size: 10pt">Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</DIV>


<P align="center" style="font-size: 10pt">Date of Report (Date of earliest event reported): December&nbsp;16, 2004


<P align="center" style="font-size: 10pt">Aspect Medical Systems, Inc.

<DIV align="center" style="font-size: 10pt"><HR size="1" noshade width="100%" align="center">
(Exact Name of Registrant as Specified in Charter)</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">Delaware
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">000-24663
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">04-2985553</TD>
</TR>

<TR style="font-size: 1px">
    <TD colspan="5" valign="top" align="left"><HR size="1" noshade>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or Other Juris-<BR>
diction of Incorporation
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission<BR>
File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(IRS Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">141 Needham Street<BR>
Newton, Massachusetts
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">02464-1505</TD>
</TR>

<TR style="font-size: 1px">
    <TD colspan="3" valign="top" align="left"><HR size="1" noshade>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">Registrant&#146;s telephone number, including area code: (617)&nbsp;559-7000


<P align="center" style="font-size: 10pt">&nbsp;

<DIV align="center" style="font-size: 10pt"><HR size="1" noshade width="100%" align="center">
(Former Name or Former Address, if Changed Since Last Report)</DIV>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (<I>see </I>General
Instruction A.2. below):


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right"><FONT style="font-family: Wingdings">&#168;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right"><FONT style="font-family: Wingdings">&#168;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right"><FONT style="font-family: Wingdings">&#168;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right"><FONT style="font-family: Wingdings">&#168;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD></TD><TD colspan="8"><A HREF="#000">Item&nbsp;5.02 &#151; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;8.01 &#151; Other Events</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#002">Item&nbsp;9.01 &#151; Financial Statements and Exhibits</A></TD></TR>
<TR><TD colspan="9"><A HREF="#003">SIGNATURE</A></TD></TR>
<TR><TD colspan="9"><A HREF="#004">EXHIBIT INDEX</A></TD></TR>
<TR><TD colspan="9"><A HREF="b52897amexv99w1.htm">EX-99.1 - Press Release dated December 17, 2004</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>




<!-- link2 "Item&nbsp;5.02 &#151; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers" -->
<DIV align="left"><A NAME="000"></A></DIV>

<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><B>Item&nbsp;5.02 &#150;</B>&nbsp;</TD>
    <TD><B>Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers</B></TD>
</TR>
</TABLE>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On December&nbsp;16, 2004, the board of directors of Aspect Medical Systems, Inc. (the &#147;Company&#148;)
elected David Feigal as a Class&nbsp;I director of the Company, to serve until the 2007 annual meeting
of stockholders of the Company. Upon his election, the Company granted Mr.&nbsp;Feigal a stock option
to purchase 10,000 shares of common stock of the Company at an exercise price equal to $23.62,
the closing price of the Registrant&#146;s common stock on the NASDAQ National Market on December&nbsp;16,
2004.

<!-- link2 "Item&nbsp;8.01 &#151; Other Events" -->
<DIV align="left"><A NAME="001"></A></DIV>

<P align="left" style="font-size: 10pt"><B>Item&nbsp;8.01 &#150; Other Events</B>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company issued a press release on December&nbsp;17, 2004 announcing Mr.&nbsp;Feigal&#146;s election to
the Company&#146;s board of directors. The full text of the press release is attached as Exhibit&nbsp;99.1
to this Current Report on Form 8-K.

<!-- link2 "Item&nbsp;9.01 &#151; Financial Statements and Exhibits" -->
<DIV align="left"><A NAME="002"></A></DIV>

<P align="left" style="font-size: 10pt"><B>Item&nbsp;9.01 &#151; Financial Statements and Exhibits</B>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Exhibits</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>See Exhibit&nbsp;Index attached hereto.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>

<!-- link1 "SIGNATURE" -->
<DIV align="left"><A NAME="003"></A></DIV>

<P align="center" style="font-size: 10pt">SIGNATURE


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">ASPECT MEDICAL SYSTEMS, INC.</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="center" nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">Date: December 22, 2004&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Nassib G. Chamoun&nbsp;
<HR size="1" noshade width="70%">
Nassib G. Chamoun&nbsp;<BR>
President and
Chief Executive Officer&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>
<!-- link1 "EXHIBIT INDEX" -->
<DIV align="left"><A NAME="004"></A></DIV>

<P align="center" style="font-size: 10pt">EXHIBIT INDEX

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="90%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="12%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="84%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><U>Exhibit&nbsp;No.</U>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><U>Description</U></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release, dated December&nbsp;17, 2004.</TD>
</TR>

<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>b52897amexv99w1.htm
<DESCRIPTION>EX-99.1 - PRESS RELEASE DATED DECEMBER 17, 2004
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.1 - Press Release dated December 17, 2004</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="right" style="font-size: 10pt">Exhibit&nbsp;99.1


<P align="center" style="font-size: 10pt"><B>Aspect Medical Systems Appoints Dr.&nbsp;David W. Feigal Jr. to Board of Directors</B>


<P align="left" style="font-size: 10pt">NEWTON, Mass.&#151;(BUSINESS WIRE)&#151;Dec. 17, 2004&#151;Aspect Medical Systems, Inc.
(NASDAQ: ASPM) today announced the appointment of David W. Feigal Jr., M.D.,
M.P.H., to its board of directors. Dr.&nbsp;Feigal brings to the board more than 20
years of experience in health policy, medical education, and healthcare
regulation. Dr.&nbsp;Feigal spent 12&nbsp;years at the U.S. Food and Drug Administration
(FDA)&nbsp;where he served in director level positions for the Center for Devices
and Radiological Health, the Center for Biologics Evaluation and Research, and
the Center for Drug Evaluation and Research. In 2004, Dr.&nbsp;Feigal stepped down
from the FDA and joined NDA Partners, LLP where he advises mid-stage device and
biopharmaceutical companies about clinical and regulatory strategies, product
development and design, and the introduction of innovative technologies. Dr.
Feigal was a member of the World Health Organization&#146;s Global Program on AIDS
and has held faculty appointments at the University of California, San
Francisco and the University of California, San Diego schools of medicine. He
holds an M.D. degree from Stanford University and an M.P.H. from the University
of California Berkeley.


<P align="left" style="font-size: 10pt">&#147;We are delighted to welcome Dr.&nbsp;Feigal to Aspect&#146;s board of directors,&#148; said
J. Breckenridge Eagle, chairman of the board of directors for Aspect. &#147;Dr.
Feigal&#146;s background and experience will be invaluable to Aspect, particularly
as we seek to introduce new applications for our brain monitoring technology to
aid the diagnosis and treatment of neurological diseases in an increasingly
complex international regulatory environment.&#148;


<P align="left" style="font-size: 10pt">Commenting on the appointment to Aspect&#146;s board, Dr.&nbsp;Feigal stated, &#147;Aspect has
an impressive track record of developing practical brain monitoring products
and efficiently conducting clinical outcome research.&#148; He continued, &#147;The
company is making a significant impact on improving the quality and safety of
patient care during anesthesia, and I look forward to helping the Aspect team
achieve its goal of making brain monitoring a routine part of anesthesia and
sedation, as well as a tool to aid the diagnosis and management of neurological
diseases such as Alzheimer&#146;s and depression.&#148;


<P align="left" style="font-size: 10pt">Aspect Medical Systems, Inc.


<P align="left" style="font-size: 10pt">Aspect Medical Systems, Inc. (NASDAQ: ASPM) is a global market leader in brain
monitoring technology. Aspect&#146;s BIS technology directly measures the effects of
anesthetics and sedatives on the brain. The technology has been used to assess
nearly 10&nbsp;million patients and has been the subject of approximately 1,700
published articles and abstracts. BIS technology is installed in approximately
one third of all domestic operating rooms and is available in more than 160
countries. Aspect Medical Systems has OEM agreements with seven leading
manufacturers of patient monitoring systems. For more information, visit
Aspect&#146;s Web site at http://www.aspectmedical.com.


<P align="left" style="font-size: 10pt">Safe Harbor Statement


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<P align="left" style="font-size: 10pt">Certain statements in this release are forward-looking and may involve risks
and uncertainties. There are a number of important factors that could cause
actual results to differ materially from those indicated by these
forward-looking statements. These factors include a number of risks facing the
Company&#146;s business. For example, the Company may not be able to achieve
widespread market acceptance of its BIS monitoring technology or to compete
with new products or alternative techniques that may be developed by others,
including third-party anesthesia monitoring products approved by the FDA, and
also faces competitive and regulatory risks relating to its ability to
successfully develop and introduce enhancements and new products. In addition,
the Company may not successfully monitor the risk of awareness with BIS
monitoring in all cases. Cases of awareness with recall during monitoring with
the BIS system and significant product liability claims are among the factors
that could limit market acceptance. There are additional factors that could
cause Aspect&#146;s actual results to vary from its forward-lookin
g statements, including without limitation those set forth under the heading &#147;Factors
Affecting Future Operating Results&#148; in Aspect&#146;s Quarterly Report on Form&nbsp;10-Q
for the fiscal quarter ended October&nbsp;2, 2004, as filed with the Securities and
Exchange Commission. In addition, any forward-looking statements represent
Aspect&#146;s views only as of the date of this press release and should not be
relied upon as representing Aspect&#146;s views as of any subsequent date. While
Aspect may elect to update forward-looking statements in the future, it
specifically disclaims any obligation to do so, even if its expectations
change. Therefore, you should not rely on these forward-looking statements as
representing Aspect&#146;s views as of any date subsequent to the date of this press
release.


<P align="left" style="font-size: 10pt">BIS, the BIS logo and Bispectral Index are trademarks of Aspect Medical
Systems, Inc. and are registered in the USA, EU and other countries. BISx,
Power Link and BIS Ready are trademarks of Aspect Medical Systems, Inc. All
other trademarks, service marks and company names are the property of their
respective owners.


<P align="left" style="font-size: 10pt">CONTACT: Aspect<BR>
Emily Anderson<BR>
Office: 617-559-7032<BR>
Mobile: 617-515-2000<BR>
eanderson@aspectms.com



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
